TOKYO, Sep 30 (Reuters) - A Japanese health ministry panel on Thursday recommended revising the nation's drug laws to allow for the importation and use of medicinal marijuana products.
The recommendation was based on meeting medical needs and to harmonise Japan with international standards, the committee said in a report. The revision would apply to marijuana products whose safety and efficacy were confirmed under laws governing pharmaceuticals and medical devices.
Revision of the law would be necessary for the use of the cannabis-derived epilepsy drug Epidiolex, which is currently undergoing clinical trials in Japan, the report said. ...continue reading
Source: ANNnewsCH